Physician profile
Krithiga Hasbrook
NPI 1215370010
$775.88
in general payments reported to CMS, 2019-2025
20 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $262 · 2022: $273 · 2023: $120 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuropace, INC. | $121.26 | 2025 | |
| Abbvie INC. | $101.41 | 2021-2023 | |
| Sk Life Science, INC. | $71.75 | 2021-2023 | |
| Neurelis, INC. | $45.71 | 2021-2023 | Valtoco |
| Eisai INC. | $43.75 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.24 | 2021-2022 | |
| Aquestive Therapeutics, INC. | $42.10 | 2022 | |
| Travere Therapeutics, INC. | $40.75 | 2021-2022 | |
| Ucb, INC. | $33.68 | 2021-2023 | Briviact |
| Biohaven Pharmaceutical Holding Company Ltd. | $30.71 | 2022 | |
| Tris Pharma INC | $30.53 | 2022 | |
| Immedica Pharma US, INC. | $29.61 | 2022-2023 | |
| Harmony Biosciences LLC | $29.30 | 2021 | |
| Greenwich Biosciences, INC. | $19.31 | 2021 | |
| Impel Pharmaceuticals INC. | $18.68 | 2023 | Trudhesa |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $15.95 | 2022 | |
| Ironshore Pharmaceuticals INC. | $15.03 | 2021 | |
| Lilly USA, LLC | $15.00 | 2021 | |
| Jazz Pharmaceuticals INC. | $14.72 | 2021 | |
| Lundbeck LLC | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krithiga Hasbrook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.